Literature DB >> 26701216

Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment.

Larissa Fabritz1,2, Eduard Guasch3,4, Charalambos Antoniades5, Isabel Bardinet6, Gerlinde Benninger7, Tim R Betts5, Eva Brand8, Günter Breithardt2,7, Gabriela Bucklar-Suchankova9, A John Camm10,11, David Cartlidge12, Barbara Casadei5, Winnie W L Chua1, Harry J G M Crijns13,14, Jon Deeks15, Stéphane Hatem16, Françoise Hidden-Lucet16, Stefan Kääb17,18, Nikos Maniadakis19, Stephan Martin6, Lluis Mont3,4, Holger Reinecke20, Moritz F Sinner17, Ulrich Schotten13,14, Taunton Southwood21, Monika Stoll13,14, Panos Vardas22, Reza Wakili17,18, Andy West12, André Ziegler9, Paulus Kirchhof1,2,7,23,24.   

Abstract

Despite remarkable advances in antiarrhythmic drugs, ablation procedures, and stroke-prevention strategies, atrial fibrillation (AF) remains an important cause of death and disability in middle-aged and elderly individuals. Unstructured management of patients with AF sharply contrasts with our detailed, although incomplete, knowledge of the mechanisms that cause AF and its complications. Altered calcium homeostasis, atrial fibrosis and ageing, ion-channel dysfunction, autonomic imbalance, fat-cell infiltration, and oxidative stress, in addition to a susceptible genetic background, contribute to the promotion, maintenance, and progression of AF. However, clinical management of patients with AF is currently guided by stroke risk parameters, AF pattern, and symptoms. In response to this apparent disconnect between the known pathophysiology of AF and clinical management, we propose a roadmap to develop a set of clinical markers that reflect the major causes of AF in patients. Thereby, the insights into the mechanisms causing AF will be transformed into a format that can underpin future personalized strategies to prevent and treat AF, ultimately informing better patient care.

Entities:  

Mesh:

Year:  2015        PMID: 26701216     DOI: 10.1038/nrcardio.2015.194

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  90 in total

1.  Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.

Authors:  Babar Parvez; Joseph Vaglio; Shane Rowan; Raafia Muhammad; Gayle Kucera; Tanya Stubblefield; Shannon Carter; Dan Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

2.  Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat.

Authors:  Jens Eckstein; Bart Maesen; Dominik Linz; Stef Zeemering; Arne van Hunnik; Sander Verheule; Maurits Allessie; Ulrich Schotten
Journal:  Cardiovasc Res       Date:  2010-10-26       Impact factor: 10.787

3.  Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation.

Authors:  Eugene Patterson; Sunny S Po; Benjamin J Scherlag; Ralph Lazzara
Journal:  Heart Rhythm       Date:  2005-06       Impact factor: 6.343

4.  Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

Authors:  Paulus Kirchhof; Gregory Y H Lip; Isabelle C Van Gelder; Jeroen Bax; Elaine Hylek; Stefan Kääb; Ulrich Schotten; Karl Wegscheider; Giuseppe Boriani; Michael Ezekowitz; Hans Diener; Hein Heidbuchel; Deirdre Lane; Luis Mont; Stephan Willems; Paul Dorian; Panos Vardas; Günter Breithardt; A John Camm
Journal:  Thromb Haemost       Date:  2011-11-02       Impact factor: 5.249

5.  MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation.

Authors:  Kristin Dawson; Reza Wakili; Balázs Ordög; Sebastian Clauss; Yu Chen; Yuki Iwasaki; Niels Voigt; Xiao Yan Qi; Moritz F Sinner; Dobromir Dobrev; Stefan Kääb; Stanley Nattel
Journal:  Circulation       Date:  2013-03-04       Impact factor: 29.690

6.  Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study.

Authors:  Hiroshi Watanabe; Toru Watanabe; Shigeru Sasaki; Kojiro Nagai; Dan M Roden; Yoshifusa Aizawa
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

7.  CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan.

Authors:  Tze-Fan Chao; Chia-Jen Liu; Su-Jung Chen; Kang-Ling Wang; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Tsu-Juey Wu; Tzeng-Ji Chen; Shih-Ann Chen
Journal:  Int J Cardiol       Date:  2012-12-29       Impact factor: 4.164

8.  Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.

Authors:  Svetlana N Reilly; Raja Jayaram; Keshav Nahar; Charalambos Antoniades; Sander Verheule; Keith M Channon; Nicholas J Alp; Ulrich Schotten; Barbara Casadei
Journal:  Circulation       Date:  2011-08-15       Impact factor: 29.690

Review 9.  A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference.

Authors:  Paulus Kirchhof; Günter Breithardt; Jeroen Bax; Gerlinde Benninger; Carina Blomstrom-Lundqvist; Giuseppe Boriani; Axel Brandes; Helen Brown; Martina Brueckmann; Hugh Calkins; Melanie Calvert; Vincent Christoffels; Harry Crijns; Dobromir Dobrev; Patrick Ellinor; Larissa Fabritz; Thomas Fetsch; S Ben Freedman; Andrea Gerth; Andreas Goette; Eduard Guasch; Guido Hack; Laurent Haegeli; Stephane Hatem; Karl Georg Haeusler; Hein Heidbüchel; Jutta Heinrich-Nols; Francoise Hidden-Lucet; Gerd Hindricks; Steen Juul-Möller; Stefan Kääb; Lukas Kappenberger; Stefanie Kespohl; Dipak Kotecha; Deirdre A Lane; Angelika Leute; Thorsten Lewalter; Ralf Meyer; Lluis Mont; Felix Münzel; Michael Nabauer; Jens C Nielsen; Michael Oeff; Jonas Oldgren; Ali Oto; Jonathan P Piccini; Art Pilmeyer; Tatjana Potpara; Ursula Ravens; Holger Reinecke; Thomas Rostock; Joerg Rustige; Irene Savelieva; Renate Schnabel; Ulrich Schotten; Lars Schwichtenberg; Moritz F Sinner; Gerhard Steinbeck; Monika Stoll; Luigi Tavazzi; Sakis Themistoclakis; Hung Fat Tse; Isabelle C Van Gelder; Panagiotis E Vardas; Timo Varpula; Alphons Vincent; David Werring; Stephan Willems; André Ziegler; Gregory Y H Lip; A John Camm
Journal:  Europace       Date:  2015-10-18       Impact factor: 5.214

10.  The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.

Authors:  Gareth J Wynn; Derick M Todd; Matthew Webber; Laura Bonnett; James McShane; Paulus Kirchhof; Dhiraj Gupta
Journal:  Europace       Date:  2014-02-16       Impact factor: 5.214

View more
  44 in total

1.  Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.

Authors:  A Mantovani; R Rigolon; A Civettini; B Bolzan; G Morani; S Bonapace; C Dugo; G Zoppini; E Bonora; G Targher
Journal:  J Endocrinol Invest       Date:  2017-07-15       Impact factor: 4.256

Review 2.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

Review 3.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marín; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

4.  Cardiac MRI for detecting left atrial/left atrial appendage thrombus in patients with atrial fibrillation : Meta-analysis and systematic review.

Authors:  J Chen; H Zhang; D Zhu; Y Wang; S Byanju; M Liao
Journal:  Herz       Date:  2018-01-26       Impact factor: 1.443

5.  Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).

Authors:  Hooman Kamel; Traci M Bartz; Mitchell S V Elkind; Peter M Okin; Evan L Thacker; Kristen K Patton; Phyllis K Stein; Christopher R deFilippi; Rebecca F Gottesman; Susan R Heckbert; Richard A Kronmal; Elsayed Z Soliman; W T Longstreth
Journal:  Stroke       Date:  2018-03-13       Impact factor: 7.914

Review 6.  Diagnosis, pathophysiology, and management of exercise-induced arrhythmias.

Authors:  Eduard Guasch; Lluís Mont
Journal:  Nat Rev Cardiol       Date:  2016-11-10       Impact factor: 32.419

7.  Increased thin filament activation enhances alternans in human chronic atrial fibrillation.

Authors:  Melanie A Zile; Natalia A Trayanova
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

8.  Chamber-specific differences in human cardiac fibroblast proliferation and responsiveness toward simvastatin.

Authors:  Farhan Rizvi; Alessandra DeFranco; Ramail Siddiqui; Ulugbek Negmadjanov; Larisa Emelyanova; Alisher Holmuhamedov; Gracious Ross; Yang Shi; Ekhson Holmuhamedov; David Kress; A Jamil Tajik; Arshad Jahangir
Journal:  Am J Physiol Cell Physiol       Date:  2016-06-22       Impact factor: 4.249

9.  The Biomarkers NT-proBNP and CA-125 are Elevated in Patients with Idiopathic Atrial Fibrillation.

Authors:  Elton Amp Dudink; Bob Weijs; Samantha Tull; Justin Glm Luermans; Larissa Fabritz; Winnie Chua; Michiel Rienstra; Isabelle C Van Gelder; Ulrich Schotten; Paulus Kirchhof; Harry Jgm Crijns
Journal:  J Atr Fibrillation       Date:  2018-12-31

Review 10.  Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

Authors:  Stanley Nattel; Philip T Sager; Jörg Hüser; Jordi Heijman; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.